MetabolomicsWorkbenchapplication/xmlhttp://www.metabolomicsworkbench.org/rest/study/study_id/ST000681/mwtabprimaryOK200MetabolomicsMass SpectrometryESIMus Musculushttp://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&StudyID=ST000681CRE:Tyrosinase Cre | SEX:fCRE:negative | SEX:mCRE:Tyrosinase Cre | SEX:mCRE:LysM Cre | SEX:fCRE:negative | SEX:fEye TissueUniversity of MichiganC18 NEGATIVE ION MODE. C18 POSITIVE ION MODE.MetabolomicsWorkbenchPE 36:1; [M-H]-@7.34PS 42:6; [M-H]-@6.50FFA(18:0)plasmenyl-PE 38:3; [M-H]-@7.52TG 58:7; [M+NH4]+@10.53PG 44:11; [M-H]-@4.74DG 36:1; [M+NH4]+@8.48TG 42:0; [M+NH4]+@9.78FFA(24:0)lysoPE 16:0; [M+H]+@1.66plasmenyl-PC 34:1; [M+Na]+@7.14PC 32:3; [M+H]+@6.05SM 33:1; [M+Na]+@5.55plasmenyl-PE 42:4; [M+H]+@8.15DG 36:2; [M+NH4]+@8.10PE 38:3; [M-H]-@7.23FFA(20:4) Arachidonic acidPC 35:1; [M-Ac-H]-@6.96PC 40:2; [M-Ac-H]-@7.96FFA(18:1)TG 62:14; [M+NH4]+@9.82PC 32:0; [M-Ac-H]-@6.46PE 35:0; [M-H]-@7.50PI 38:4; [M-H]-@5.87PG 36:2; [M-H]-@5.94plasmenyl-PC 36:3; [M+Na]+@6.77PC 44:12; [M-Ac-H]-@5.49PE 36:2; [M+H]+@7.00FFA(24:1)TG 62:12; [M+NH4]+@10.24PC 40:4; [M-Ac-H]-@7.22TG 53:1; [M+NH4]+@10.94PC 38:4; [M-Ac-H]-@6.68lysoPC 16:0; [M+H]+@1.59PG 44:10; [M-H]-@5.10TG 56:4; [M+NH4]+@10.77SM 37:2; [M]+@6.45DG 44:12; [M+NH4]+@6.99PS 38:6; [M-H]-@5.21plasmenyl-PE 38:5; [M+H]+@6.88PC 37:4; [M-Ac-H]-@6.44PE 42:5; [M+H]+@7.65TG 50:0; [M+NH4]+@10.79PC 30:1; [M+Na]+@5.49SM 35:1; [M]+@6.22CL 70:3; [M-2H](2-)@9.57PE 35:4; [M-H]-@6.00PC 36:3; [M-Ac-H]-@6.37lysoPE 18:2; [M+H]+@1.37TG 58:5; [M+NH4]+@10.80DG 40:4; [M+NH4]+@8.43CL 72:5; [M-2H](2-)@9.44lysoPE 22:6; [M+H]+@1.32TG 48:2; [M+NH4]+@10.16TG 53:0; [M+NH4]+@11.16PC 34:2; [M-Ac-H]-@6.14PS 38:5; [M-H]-@5.52TG 50:2; [M+NH4]+@10.39PG 42:9; [M-H]-@4.87SM 41:2; [M]+@7.71PE 34:2; [M+H]+@6.43PC 40:8; [M+H]+@6.45PE 34:1; [M+H]+@6.86TG 52:6; [M+NH4]+@9.81plasmenyl-PE 40:4; [M+H]+@7.68TG 50:5; [M+NH4]+@9.76TG 54:4; [M+NH4]+@10.48PI 36:2; [M-H]-@5.93PS 40:4; [M-H]-@6.46TG 60:10; [M+NH4]+@10.33plasmenyl-PE 42:6; [M+H]+@7.78TG 54:6; [M+NH4]+@10.15PC 34:3; [M-Ac-H]-@5.66PE 40:8; [M+H]+@5.97PS 42:10; [M-H]-@4.80PC 38:1; [M-Ac-H]-@7.73TG 60:13; [M+NH4]+@9.76PC 50:6; [M+Na]+@8.95PS 40:8; [M-H]-@4.86PE 44:12; [M-H]-@5.65PC 31:0; [M-Ac-H]-@6.20PC 39:6; [M-Ac-H]-@6.35TG 58:10; [M+NH4]+@10.05lysoPC 20:1; [M+H]+@2.56SM 34:2; [M+Na]+@5.33PS 40:6; [M-H]-@5.89TG 54:8; [M+NH4]+@9.71PC 34:4; [M+Na]+@5.63FFA(22:2)TG 54:3; [M+NH4]+@10.67PE 42:10; [M-H]-@5.77PG 42:10; [M-H]-@4.63SM 42:2; [M+Na]+@7.82PC 36:1; [M-Ac-H]-@7.16PE 40:7; [M+H]+@6.37SM 32:2; [M+Na]+@4.55N-(hexadecanoyl)-sphing-4-enine; [M-H]-@6.77plasmenyl-PE 32:0; [M-H]-@7.01DG 34:0; [M+NH4]+@8.40PE 42:11; [M+Na]+@5.44PG 44:12; [M-H]-@4.48SM 37:1; [M]+@6.90PG 34:1; [M-H]-@5.81PE 40:4; [M+H]+@7.42TG 54:2; [M+NH4]+@10.87TG 44:1; [M+NH4]+@9.80PC 42:4; [M+Na]+@7.85PE 37:4; [M-H]-@6.63DG 40:6; [M+NH4]+@7.97lysoPE 18:1; [M+H]+@1.85DG 38:4; [M+NH4]+@8.05PC 40:9; [M+Na]+@5.49TG 56:5; [M+NH4]+@10.61FFA(22:3)PC 36:4; [M-Ac-H]-@6.12DG 42:10; [M+NH4]+@7.06PS 36:4; [M-H]-@5.31TG 48:3; [M+NH4]+@9.89DG 38:5; [M+NH4]+@7.66PE 37:6; [M+H]+@5.99FFA(16:0)PG 36:3; [M-H]-@5.61TG 52:1; [M+NH4]+@10.80PE 38:1; [M-H]-@7.83PE 38:4; [M+H]+@7.01PC 38:3; [M-Ac-H]-@7.00PE 38:2; [M+H]+@7.58PG 38:4; [M-H]-@6.02PE 38:5; [M+H]+@6.54FFA(22:0)DG 35:1; [M+NH4]+@8.20plasmenyl-PE 36:2; [M+H]+@7.34plasmenyl-PE 38:4; [M+H]+@7.27DG 36:0; [M+NH4]+@8.88TG 52:5; [M+NH4]+@10.06PC 38:2; [M-Ac-H]-@7.31MG 17:0; [M+Li]+@3.15PC 36:0; [M-Ac-H]-@7.66PS 34:2; [M-H]-@5.30PS 42:7; [M-H]-@5.99TG 50:3; [M+NH4]+@10.20plasmenyl-PE 32:1; [M-H]-@6.51PE 40:10; [M-H]-@5.07PG 36:5; [M-H]-@5.05TG 49:2; [M+NH4]+@10.28DG 36:3; [M+NH4]+@7.76TG 66:18; [M+NH4]+@9.68PS 42:9; [M-H]-@5.07plasmenyl-PC 18:0; [M+Na]+@1.68TG 54:7; [M+NH4]+@10.03PC 42:6; [M-Ac-H]-@7.30PC 42:11; [M+Na]+@5.36plasmenyl-PE 40:6; [M+H]+@7.21FFA(22:1)PS 44:12; [M-H]-@4.69PE 21:4; [M+H]+@1.42PE 32:1; [M+H]+@6.26SM 42:1; [M+Na]+@8.32PE 40:5; [M+H]+@7.11TG 48:1; [M+NH4]+@10.35PE 46:10; [M+H]+@6.88TG 58:11; [M+NH4]+@9.81PE 42:7; [M+H]+@7.01PE 42:6; [M-H]-@7.40PC 28:0; [M-Ac-H]-@5.17PE 40:9; [M-H]-@5.52PS 44:11; [M-H]-@4.92TG 56:9; [M+NH4]+@9.87TG 58:6; [M+NH4]+@10.72plasmenyl-PE 40:5; [M+H]+@7.33CL 72:4; [M-2H](2-)@9.62PC 48:6; [M+Na]+@8.48TG 52:2; [M+NH4]+@10.61PS 38:4; [M-H]-@5.94PC 42:9; [M+H]+@6.86SM 30:1; [M]+@4.41PE 42:8; [M+H]+@6.52PE 32:0; [M-H]-@6.67PC 38:7; [M+Na]+@5.66CL 74:7; [M-2H](2-)@9.52PE 44:10; [M-H]-@6.29plasmenyl-PE 36:1; [M+H]+@7.75lysoPE 18:0; [M+H]+@2.50plasmenyl-PC 32:0; [M+Na]+@7.04TG 56:0; [M+NH4]+@11.50plasmenyl-PE 36:5; [M+H]+@6.34SM 34:1; [M]+@5.83PC 33:1; [M-Ac-H]-@6.36TG 58:8; [M+NH4]+@10.37PG 32:0; [M-H]-@5.77PE 36:6; [M+H]+@5.62PS 36:2; [M-H]-@5.98SM 34:0; [M+Na]+@6.16TG 49:1; [M+NH4]+@10.49TG 64:16; [M+NH4]+@9.76PI 36:4; [M-H]-@5.21plasmenyl-PE 34:1; [M-H]-@7.07PS 38:3; [M-H]-@6.19PE 36:0; [M-H]-@7.77PC 38:6; [M-Ac-H]-@5.97PG 38:5; [M-H]-@5.55PG 33:0; [M-H]-@6.04PC 36:5; [M-Ac-H]-@5.60TG 56:8; [M+NH4]+@10.10PC 33:2; [M-Ac-H]-@5.88PC 42:10; [M+Na]+@5.78FFA(20:2)lysoPC 15:0; [M+H]+@1.40N-(octadecanoyl)-sphing-4-enine; [M-H]-@7.37PS 34:1; [M-H]-@5.98TG 52:4; [M+NH4]+@10.23plasmenyl-PE 36:0; [M+H]+@8.22lysoPC 22:4; [M+H]+@1.91lysoPC 18:0; [M+Na]+@2.27TG 54:1; [M+NH4]+@11.06plasmenyl-PC 20:0; [M+Na]+@2.59SM 36:1; [M]+@6.71plasmenyl-PE 34:2; [M-H]-@6.64PS 40:7; [M-H]-@5.37lysoPC 16:1; [M+H]+@1.39PE 42:9; [M-H]-@6.05PC 38:5; [M-Ac-H]-@6.33TG 46:0; [M+NH4]+@10.34PC 32:1; [M-Ac-H]-@5.99TG 46:1; [M+NH4]+@10.09SM 44:2; [M]+@8.36TG 56:7; [M+NH4]+@10.27SM 36:2; [M]+@6.01PE 38:6; [M+H]+@6.17plasmenyl-PE 36:3; [M-H]-@6.89PG 40:6; [M-H]-@5.98PC 34:1; [M-Ac-H]-@6.57plasmenyl-PE 38:1; [M-H]-@8.13FFA(20:0)plasmenyl-PE 34:0; [M+H]+@7.66TG 51:1; [M+NH4]+@10.71TG 60:12; [M+NH4]+@9.97lysoPC 19:0; [M+H]+@2.94PC 37:6; [M-Ac-H]-@5.74PC 35:2; [M+Na]+@6.64TG 50:4; [M+NH4]+@9.96lysoPC 22:5; [M+Na]+@1.57TG 58:1; [M+NH4]+@11.55plasmenyl-PE 38:6; [M+H]+@6.58plasmenyl-PE 42:5; [M-H]-@7.79PC 40:5; [M+H]+@7.60TG 44:2; [M+NH4]+@9.55PC 42:7; [M-Ac-H]-@6.75PS 42:11; [M-H]-@4.38DG 38:3; [M+NH4]+@8.31PC 38:4; [M+H]+@8.85PE 34:3; [M+H]+@5.91plasmenyl-PE 38:2; [M-H]-@7.79PE 36:4; [M+H]+@6.34PG 34:2; [M-H]-@5.43SM 40:1; [M+Na]+@7.78TG 56:6; [M+NH4]+@10.48DG 38:6; [M+NH4]+@7.44FFA(20:1)PC 40:7; [M-Ac-H]-@6.14TG 54:5; [M+NH4]+@10.32TG 58:9; [M+NH4]+@10.17PG 40:8; [M-H]-@4.65lysoPE 20:4; [M+H]+@1.38PG 40:7; [M-H]-@5.18PE 40:6; [M+H]+@6.88PC 40:6; [M-Ac-H]-@6.60PE 41:6; [M-H]-@7.06PG 36:4; [M-H]-@5.42FFA(18:2)TG 62:11; [M+NH4]+@10.32PG 38:6; [M-H]-@5.35CL 76:11; [M-2H](2-)@9.02PC 35:4; [M+Na]+@5.99PC 36:2; [M-Ac-H]-@6.73lysoPC 14:0; [M+H]+@1.14plasmenyl-PC 34:2; [M+Na]+@6.72plasmenyl-PE 36:4; [M+H]+@6.69PC 32:2; [M-Ac-H]-@5.53SM 41:1; [M]+@8.11PE 36:3; [M-H]-@6.46DG 36:4; [M+NH4]+@7.53PE 36:5; [M+H]+@5.92TG 52:0; [M+NH4]+@11.02TG 46:2; [M+NH4]+@9.81PC 30:0; [M-Ac-H]-@5.85PC 36:6; [M-Ac-H]-@5.40PE 39:6; [M+H]+@6.61PS 44:10; [M-H]-@5.31SM 39:1; [M]+@7.54TG 50:1; [M+NH4]+@10.58lysoPC 19:0; [M+Na]+@2.92DG 32:0; [M+NH4]+@7.88DG 34:2; [M+NH4]+@7.61TG 52:3; [M+NH4]+@10.45TG 64:15; [M+NH4]+@9.86PE 38:7; [M+H]+@5.98FFA(24:3)PC 32:0; [M+H]+@6.59study, Lyzs, Lzp, (3beta, AI326280., Vitamin A Aldehyde, Vitamin A, Tissue, Cholest-5-en-3beta-ol, Retinyl, Retinene, Epicholesterol, 6-trimethyl-1-cyclohexen-1-yl)-2, Retinyl Aldehydde, 11 cis Retinal, Lysm, Axerophthal, all-trans-Retinal, 7-dimethyl-9-(2, Lys, 11-trans-Retinal, Cholest-5-en-3-ol (3beta)-, all trans Retinal, Aldehyde, efflux, Aldehydde, 17alpha)-cholest-5-en-3-ol, 3, 4, simple tissue, 11-cis-Retinal, Lzm-s1, 6, Cholesterin, 14beta, 8-Nonatetraenal, Retinal, 11 trans Retinal, LzmC18, D1, PTHB1, B1, B1.falseRetinal tissue knockout to study efflux of cholesterol (AGCA1/G1 double KO - TY and LysM cre)ST00068110090